article thumbnail

Correlation between baseline immature platelets fraction levels and peak troponin in patients with acute myocardial infarction

Coronary Artery Disease Journal

Introduction Elevated peak cardiac troponin levels have been linked with increased morbidity and mortality in patients with acute myocardial infarction (AMI). We hypothesize that patients with higher IPF levels during AMI, will experience a more severe infarct, leading to elevated peak troponin levels.

article thumbnail

Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data

Circulation: Cardiovascular Quality & Outcomes

Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. This could facilitate more accurate longitudinal assessments of acute myocardial infarction quality and outcomes. T1MI and 53.5%

article thumbnail

Prehospital identification of ST-segment elevation myocardial infarction and mortality (ANZACS-QI 61)

Open Heart

Background Early recognition of ST-segment elevation myocardial infarction (STEMI) is needed for timely cardiac monitoring and reperfusion therapy.

article thumbnail

Construction and validation of a predictive model for major adverse cardiovascular events in the long term after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction

Coronary Artery Disease Journal

Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).

article thumbnail

A Retrospective Cohort Study of the 2018 Angiotensin Receptor Blocker Recalls and Subsequent Drug Shortages in Patients With Hypertension

Journal of the American Heart Association

BackgroundValsartan was recalled by the US Food and Drug Administration in July 2018 for carcinogenic impurities, resulting in a drug shortage and management challenges for valsartan users. Journal of the American Heart Association, Ahead of Print. The influence of the valsartan recall on clinical outcomes is unknown.

article thumbnail

Improved Clinical Outcomes with Intravascular Imaging-Guided PCI: Impact of Standardized Optimization Protocols

Cardiology Update

The RENOVATE-COMPLEX-PCI trial demonstrated the superiority of IVI-guided PCI over angiography-guided PCI in patients undergoing complex procedures, showing significant reductions in cardiac death, target vessel-related myocardial infarction (MI), and target vessel revascularization. vs 6.7%; HR: 0.77; 95% CI: 0.61-0.97;

article thumbnail

Familial risk of vasospastic angina: a nationwide family study in Sweden

Open Heart

Objectives Vasospastic angina (VSA) is a complex coronary vasomotor disorder associated with an increased risk of myocardial infarction and sudden death. Methods A population-based multigenerational cohort study was conducted, including full-sibling pairs born to Swedish parents between 1932 and 2018.

Angina 96